Obesity Medicine

Latest News

ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions / ©design36/shutterstock.com
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions

June 20th 2025

The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.

Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial
Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial

June 20th 2025

Novo Nordisk Advances Amycretin SC and Oral into Phase 3 Development for Weight Management /image credit ©Remigiusz Góra/stock.adobe.com
Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity

June 13th 2025

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose

June 13th 2025

High Discontinuation Rates of GLP-1 RA-Based Drugs Linked to Weight Loss Far Below Phase 3 Clinical Trials / image credit ©brovarky/stock.adobe.com
High Discontinuation Rates of GLP-1 RA-Based Drugs Linked to Weight Loss Far Below Phase 3 Clinical Trials

June 12th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.